Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $444.58 | 20 | 67.9% |
| Long term medical supply or device loan | $174.06 | 2 | 26.6% |
| Gift | $19.40 | 1 | 3.0% |
| Education | $17.19 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $174.06 | 2 | $0 (2022) |
| Allergan Inc. | $141.93 | 9 | $0 (2019) |
| RxSight Inc | $111.84 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $65.66 | 4 | $0 (2020) |
| Omeros Corporation | $42.69 | 2 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $37.82 | 2 | $0 (2024) |
| Coherus Biosciences Inc. | $30.23 | 1 | $0 (2023) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Glaukos Corporation | $17.60 | 1 | $0 (2023) |
| Ellex, Inc | $14.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.82 | 2 | Apellis Pharmaceuticals, Inc. ($37.82) |
| 2023 | $47.83 | 2 | Coherus Biosciences Inc. ($30.23) |
| 2022 | $285.90 | 3 | Alcon Vision LLC ($174.06) |
| 2021 | $39.66 | 2 | Omeros Corporation ($25.66) |
| 2020 | $58.91 | 3 | Novartis Pharmaceuticals Corporation ($22.48) |
| 2019 | $80.67 | 5 | Allergan Inc. ($66.85) |
| 2018 | $104.44 | 7 | Allergan Inc. ($75.08) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Ophthalmology | ||||||
| 01/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | In-kind items and services | $17.19 | General |
| Category: Ophthalmology | ||||||
| 08/25/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Ophthalmology | ||||||
| 01/05/2023 | Glaukos Corporation | iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device), iAccess Precision Blade | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Glaucoma | ||||||
| 10/19/2022 | RxSight Inc | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) | Food and Beverage | In-kind items and services | $111.84 | General |
| Category: Ophthalmology | ||||||
| 03/16/2022 | Alcon Vision LLC | Luxor (Device) | Long term medical supply or device loan | In-kind items and services | $131.51 | General |
| Category: Ophthalmology | ||||||
| 03/16/2022 | Alcon Vision LLC | Luxor (Device) | Long term medical supply or device loan | In-kind items and services | $42.55 | General |
| Category: Ophthalmology | ||||||
| 10/18/2021 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $25.66 | General |
| Category: Ophthalmology | ||||||
| 02/01/2021 | Ellex, Inc | Tango-R SLT/YAG Combination Laser with Reflex Technology (Device) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Ophthalmology | ||||||
| 04/21/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 03/03/2020 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Ophthalmology | ||||||
| 02/04/2020 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | PAZEO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/22/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/25/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/10/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/13/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,882 | 2,981 | $1.7M | $441,396 |
| 2022 | 16 | 1,835 | 2,815 | $1.6M | $410,340 |
| 2021 | 19 | 2,045 | 3,219 | $2.0M | $507,051 |
| 2020 | 19 | 1,679 | 2,587 | $1.5M | $400,343 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 34 | 302 | $302,000 | $208,232 | 69.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 114 | 200 | $691,336 | $76,493 | 11.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 467 | 489 | $72,861 | $39,590 | 54.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 69 | 253 | $131,138 | $21,222 | 16.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 54 | 69 | $133,835 | $16,102 | 12.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 192 | 258 | $20,124 | $13,372 | 66.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 147 | 147 | $21,903 | $13,057 | 59.6% |
| 92134 | Imaging of retina | Office | 2023 | 168 | 419 | $61,174 | $11,744 | 19.2% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 15 | 17 | $62,720 | $8,943 | 14.3% |
| 65855 | Laser repair to improve eye fluid flow | Facility | 2023 | 30 | 43 | $100,280 | $6,852 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 67 | $9,983 | $6,147 | 61.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 126 | 239 | $71,939 | $6,023 | 8.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 251 | 251 | $36,646 | $5,843 | 15.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 101 | 103 | $11,536 | $4,072 | 35.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 40 | 99 | $3,762 | $2,830 | 75.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,788 | $752.76 | 42.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 13 | 13 | $585.00 | $120.50 | 20.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 34 | 278 | $278,000 | $199,415 | 71.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 107 | 179 | $629,000 | $67,917 | 10.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 486 | 506 | $75,394 | $39,271 | 52.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 64 | 87 | $165,880 | $19,068 | 11.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 60 | 207 | $110,925 | $17,318 | 15.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 213 | 283 | $22,074 | $15,277 | 69.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 122 | 122 | $18,178 | $11,005 | 60.5% |
| 92134 | Imaging of retina | Office | 2022 | 156 | 380 | $55,480 | $10,883 | 19.6% |
About Dr. Daniel Paskowitz, MD
Dr. Daniel Paskowitz, MD is a Ophthalmology healthcare provider based in West Allis, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992907885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Paskowitz, MD has received a total of $655.23 in payments from pharmaceutical and medical device companies, with $37.82 received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($444.58).
As a Medicare-enrolled provider, Paskowitz has provided services to 7,441 Medicare beneficiaries, totaling 11,602 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location West Allis, WI
- Active Since 06/03/2007
- Last Updated 07/21/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1992907885
Products in Payments
- Luxor (Device) $174.06
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $111.84
- COMBIGAN (Drug) $90.05
- LUMIGAN (Drug) $51.88
- Omidria (Drug) $42.69
- Syfovre (Drug) $37.82
- Cimerli (Biological) $30.23
- DUREZOL (Drug) $29.36
- BEOVU (Drug) $22.48
- None Specified (Medical Supply) $19.40
- iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) $17.60
- Tango-R SLT/YAG Combination Laser with Reflex Technology (Device) $14.00
- PAZEO (Drug) $13.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in West Allis
Brett Rhode, M.d, M.D
Ophthalmology — Payments: $1,026
Dr. Mark Freedman, M.d, M.D
Ophthalmology — Payments: $719.15
Daniel Ferguson, M.d, M.D
Ophthalmology — Payments: $385.81
Richard Davenport, Md, MD
Ophthalmology — Payments: $327.35
Robert Sucher, M.d, M.D
Ophthalmology